K Forfang
Impact in
-
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac Valve Diseases and Treatments
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
-
- Cardiac tumors and thrombi 4
- Cardiac electrophysiology and arrhythmias 3
- Cardiovascular Effects of Exercise 3
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Surgery 9
- Hemodynamic Monitoring and Therapy 2
- Cardiac Structural Anomalies and Repair 2
- Co-authors
- Halfdan Ihlen (5 shared papers)Jan Erikssen (2 shared papers)O Storstein (2 shared papers)E Myhre (2 shared papers)Ivar Enge (1 shared paper)Jan Amlie (2 shared papers)Jeremy Dale (1 shared paper)S Nitter‐Hauge (1 shared paper)
- Journals
- Heart (4 papers)Cardiology (4 papers)European Journal of Clinical Pharmacology (2 papers)Annals of Oncology (2 papers)Acta Paediatrica (1 paper)
- Partner nations
- NorwayIndiaSwitzerland
In The Last Decade
K Forfang
20 papers receiving 899 citations
Peers
Comparison fields: 5 of 72
- Cardiology and Cardiovascular Medicine 526
- Genetics 120
- Radiology, Nuclear Medicine and Imaging 180
- Complementary and alternative medicine 58
- Surgery 269
Countries citing papers authored by K Forfang
This map shows the geographic impact of K Forfang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Forfang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Forfang more than expected).
Fields of papers citing papers by K Forfang
This network shows the impact of papers produced by K Forfang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Forfang. The network helps show where K Forfang may publish in the future.
Co-authors
The 25 scholars most cited alongside K Forfang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 293 | |
| 2 | 1976 | 160 | |
| 3 | 2009 | 126 | |
| 4 | 1996 | 77 | |
| 5 | 2010 | 65 | |
| 6 | 1995 | 52 | |
| 7 | 1997 | 47 | |
| 8 | 1985 | 41 | |
| 9 | 1996 | 35 | |
| 10 | Exercise ECG and case history in the diagnosis of latent coronary heart disease among presumably healthy middle-aged men. | 1977 | 33 |
| 11 | 1980 | 9 | |
| 12 | 1989 | 9 | |
| 13 | 1997 | 7 | |
| 14 | 1988 | 7 | |
| 15 | 1988 | 6 | |
| 16 | [Late complications after treatment of Hodgkin's disease]. | 1999 | 4 |
| 17 | Left ventricular aneurysm and severe cardiac dysfunction: heart transplantation or aneurysm surgery? | 1990 | 4 |
| 18 | 2008 | 1 | |
| 19 | 2008 | 1 | |
| 20 | 1985 | 1 |
About K Forfang
K Forfang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 980 indexed citations. Recurring topics across this work include Cardiac tumors and thrombi (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Cardiovascular Effects of Exercise (3 papers), Cardiovascular and Diving-Related Complications (3 papers), Congenital Heart Disease Studies (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Hemodynamic Monitoring and Therapy (2 papers) and Cardiac Structural Anomalies and Repair (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (526 citations), Genetics (120 citations), Radiology, Nuclear Medicine and Imaging (180 citations), Complementary and alternative medicine (58 citations) and Surgery (269 citations). K Forfang has collaborated with scholars based in Norway, India and Switzerland. Frequent co-authors include Halfdan Ihlen, Jan Erikssen, O Storstein, E Myhre, Ivar Enge, Jan Amlie, Jeremy Dale, S Nitter‐Hauge, J. E. Otterstad and S Simonsen. Their work appears in journals such as Heart, Cardiology, European Journal of Clinical Pharmacology, Annals of Oncology and Acta Paediatrica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.